tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Seiji Wakao

Seiji Wakao

J.P. Morgan
Wall Street Analyst
Ranked #7,172 out of 8,014 Analysts on TipRanks (#19,364 out of 21,455 overall experts)

Success Rate

0%
0 out of 3 Profitable Transactions

Average Return

-38.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Seiji Wakao's ratings since 2021 and opened each position for the duration of 1 Year:
0.00% of your transactions would have been profitable with an average return of -38.3%

Stock Rating Distribution

13Ratings
61.54% Hold
38.46% Buy
0.00% Sell
Distribution of Seiji Wakao's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Shionogi & Co
(SGIOF)
Rating Type:Hold
Dates:Jan 21, 2022 - Jan 01, 1970
Gain:0.00%
The most profitable rating made by Seiji Wakao

Seiji Wakao's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
ONO Pharmaceutical Co
Hold
Reiterated
$20.28
(-18.55% Downside)
0.00%
1
Takeda Pharmaceutical Company
Hold
Reiterated
$18.00
(27.39% Upside)
0.00%
2
Takeda Pharmaceutical Co
Hold
Reiterated
0.00%
2
Eisai Co
Buy
Reiterated
$67.60
(46.65% Upside)
0%
-38.37%
5
Otsuka Holdings Co
Hold
Reiterated
$34.55
(-3.19% Downside)
0.00%
1
Shionogi & Co
Hold
Reiterated
$50.33
(-4.31% Downside)
0.00%
2
List of latest recommendations made by Seiji Wakao. Click to expand and see Seiji Wakao's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More